FDA’s Scott Gottlieb Releases Statement on Cannabis, CBD Regulation – The National Law Review

David focuses his practice on health care matters. In addition to providing advice and counsel to health care providers such as academic medical centers, acute care hospitals, physician practice groups, managed care organizations, nursing homes, assisted living facilities, and ambulatory surgery centers, he advises private equity and independent purchasers on corporate structure, fraud and abuse, anti-kickback, and regulatory and licensure matters.

David’s experience includes transactional work related to affiliations, mergers and acquisitions,…

Source: https://www.natlawreview.com/article/fda-and-outgoing-commissioner-scott-gottlieb-open-about-cannabis-and-cbd-regulation

« »